EPO Patents = 1

Forward Citations = 1

Loading Chart...

3 inventors (with patents filed for the assignee):

Paul Joseph Mark Jackson (5 out of 5 patents)

David Edwin Thurston (5 out of 21 patents)

Khondaker Mirazur Rahman (5 out of 9 patents)

5 patents: Sort by Forward Citations

1. 11466032 - Cytotoxic agents (2022-10-11),

2. 10975074 - Anti-liferative agents comprising substituted benzo[e]pyrido[1,2-a][1,4]diazepines (2021-04-13),

3. 10975072 - Substituted 6a,7,8,9,10,12-hexahydrobenzo[e]pyrido[1,2-a][1,4]diazepines as anti-proliferative agents (2021-04-13),

4. 10399970 - Pyrridinobenzodiazepine and benzopyrridodiazecine compounds (2019-09-03),

5. 9999625 - Pyrrolobenzodiazepine compounds (2018-06-19),

Femtogenix is a biotechnology company focused on developing novel DNA-interactive payloads for targeted cancer therapies. The company's proprietary payload platform enables the precise delivery of highly potent drugs to cancer cells, while minimizing off-target effects. Femtogenix's innovative approach holds great promise for improving the effectiveness and safety of cancer treatments.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

5 Patents

#555 in

#3,210 in

London, United Kingdom

Femtogenix Limited

Forward Citations = 1

3 inventors:

Paul Joseph Mark Jackson (5 out of 5 patents)

David Edwin Thurston (5 out of 21 patents)

Khondaker Mirazur Rahman (5 out of 9 patents)

Please report any incorrect information to [email protected]

1 patent (EPO):

Please report any incorrect information to [email protected]